Details for Patent: 5,948,437
✉ Email this page to a colleague
Summary for Patent: 5,948,437
Title: | Pharmaceutical compositions using thiazepine |
Abstract: | The invention relates to sustained release formulations comprising 11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f] [1,4]thiazepine or a pharmaceutically acceptable salt thereof, to methods of treating psychotic states and hyperactivity utilizing the sustained release formulations and to a process for preparing the sustained release formulations. |
Inventor(s): | Parikh; Bhavnish Vinod (Hockessin, DE), Timko; Robert Joseph (West Chester, PA), Addicks; William Joseph (Morgantown, WV) |
Assignee: | Zeneca Limited (GB) |
Application Number: | 08/864,306 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Use; Process; Dosage form; |
Drugs Protected by US Patent 5,948,437
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |